Papua New Guinea vs Sri Lanka: Average cost of tuberculosis treatment multi drug resistant
Papua New Guinea
953
in 2022
Sri Lanka
902
in 2024
Papua New Guinea rank
51st
Sri Lanka rank
52nd
Average cost of tuberculosis treatment multi drug resistant over time
- Papua New Guinea
- Sri Lanka
How they compare
Papua New Guinea currently reports 953 against 902 in Sri Lanka, a difference of 51.
That makes Papua New Guinea's figure about 1.1 times Sri Lanka's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Papua New Guinea ahead.
Papua New Guinea ranks 51st and Sri Lanka ranks 52nd of 92 countries.
Across the 2 decades both report, Papua New Guinea averaged higher in 1 and Sri Lanka in 1.
Head to head by decade
| Decade | Papua New Guinea | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,096 | 1,554 | 542 | Papua New Guinea |
| 2020s | 871.67 | 1,801 | 929 | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment multi drug resistant, Papua New Guinea or Sri Lanka?
- Papua New Guinea, at 953 against 902 in Sri Lanka as of 2022.
- What is the difference in average cost of tuberculosis treatment multi drug resistant between Papua New Guinea and Sri Lanka?
- 51, with Papua New Guinea ahead.
- How many years of comparable data are there for Papua New Guinea and Sri Lanka?
- 5 years are reported by both, from 2017 to 2022.
- How do Papua New Guinea and Sri Lanka rank globally for average cost of tuberculosis treatment multi drug resistant?
- Papua New Guinea ranks 51st and Sri Lanka ranks 52nd of 92 countries.
- Where does this data come from?
- Our World in Data, published as Average cost of tuberculosis treatment multi drug resistant. Statizoid refreshes it automatically from the source and publishes the full history for both places.